H.R. 919 · Where this bill is now
In the Senate
Passed the House Mar 4, 2025. Received Mar 5, 2025; no Senate vote yet
What this bill does
In plain words · AI-written from the official summaryCovers chronic disease preventive care without deductibles
High deductible health plans (HDHPs) have rules about when you have to pay a deductible before insurance kicks in. This bill gives legal backing to IRS guidance that lets these plans cover certain preventive medications and tests for chronic conditions—like blood pressure monitors for hypertension, insulin for diabetes, or heart medications—without charging you the deductible first. Basically, people with ongoing health conditions can get these specific preventive items and treatments covered right away.
How it affects you
If you have a high deductible health plan and live with a chronic condition like diabetes, heart disease, asthma, depression, osteoporosis, or high blood pressure, you'd benefit directly. You could access certain preventive medications and monitoring tools without having to pay your full deductible upfront, making it easier and more affordable to manage your condition.
Read the official summary (Introduced in House, Feb 4, 2025)
Chronic Disease Flexible Coverage Act
This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.
Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold.
The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include
• angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
• anti-resorptive therapy for individuals with osteoporosis or osteopenia;
• beta-blockers for individuals with congestive heart failure or coronary artery disease;
• blood pressure monitors for individuals with hypertension;
• inhaled corticosteroids and peak flow meters for individuals with asthma;
• insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
• international normalized ratio testing for individuals with liver disease or bleeding disorders;
• low-density lipoprotein testing for individuals with heart disease;
• statins for individuals with heart disease or diabetes; and
• selective serotonin reuptake inhibitors for individuals with depression.
The bill provides statutory authority for the IRS's guidance.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionH. R. 919
AN ACT
Chronic Disease Flexible Coverage Act
Sponsor: Rep. Vern Buchanan (R-FL-16) · Introduced Feb 4, 2025 · Taxation · 3 versions of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Mar 5, 2025: “Received in the Senate and Read twice and referred to the Committee on Finance.”
Sections
The wording of this bill hasn’t changed across its 3 official versions.